References

1. 1.
   Inflammatory Bowel Disease Group，Chinese Society of Gastroenterology，Chinese Medical Association.Chinese consensus on diagnosis and treatment in inflammatory bowel disease（2018，Beijing）［J］.Chin J Dig，2018，38（5）：292-311.
2. 2.
   UNGARO R，MEHANDRU S，ALLEN P B，et al.Ulcerative colitis［J］.Lancet，2017，389（10080）：1756-1770.
3. 3.
   LE BERRE C，HONAP S，PEYRIN-BIROULET L.Ulcerative colitis［J］.Lancet，2023，402（10401）：571-584.
4. 4.
   SHI R，LI J X，SHEN H，et al.Experts consensus on traditional Chinese medicine diagnosis and treatment of ulcerative colitis（2023）［J］.China J Tradit Chin Med Pharm，2024，39（1）：288-296.
5. 5.
   Chinese Association of Integrative Medicine.Expert consensus on the diagnosis and treatment of ulcerative colitis［J］.Chin J Integr Med，2023，43（1）：5-11.
6. 6.
   ZHONG F R，CHEN Y，CHEN J，et al.Jatrorrhizine：A review of sources，pharmacology，pharmacokinetics and toxicity［J］.Front Pharmacol，2021，12：783127.
7. 7.
   WANG P，GAO X Y，YANG S Q，et al.Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition［J］.Drug Des Devel Ther，2019，13：2235-2247.
8. 8.
   SUN Y F，GAO X Y，WU P P，et al.Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition （EMT）［J］.Phytomedicine，2019，63：153015.
9. 9.
   YU H M，WANG Y F，WANG X Q，et al.Jatrorrhizine suppresses the antimicrobial resistance of methicillin-resistant Staphylococcus aureus［J］.Exp Ther Med，2019，18（5）：3715-3722.
10. 10.
    NIU S Q，JING M Y，WEN J X，et al.Jatrorrhizine alleviates DSS-induced ulcerative colitis by regulating the intestinal barrier function and inhibiting TLR4/MyD88/NF-κB signaling pathway［J］.Evid Based Complement Alternat Med，2022，2022：3498310.
11. 11.
    ZHANG J L，ZHANG M N，WANG H G，et al.Jatrorrhizine alleviates ulcerative colitis via regulating gut microbiota and NOS2 expression［J］.Gut Pathog，2022，14（1）：41.
12. 12.
    WU H，HE K，WANG Y Z，et al.The antihypercholesterolemic effect of jatrorrhizine isolated from Rhizoma Coptidis［J］.Phytomedicine，2014，21（11）：1373-1381.
13. 13.
    QIU H W，SUN S N，MA X M，et al.Jatrorrhizine hydrochloride suppresses proliferation，migration，and secretion of synoviocytes in vitro and ameliorates rat models of rheumatoid arthritis in vivo［J］.Int J Mol Sci，2018，19（5）：1514.
14. 14.
    MUJALLI A，FARRASH W F，ALGHAMDI K S，et al.Metabolite alterations in autoimmune diseases：A systematic review of metabolomics studies［J］.Metabolites，2023，13（9）：987.
15. 15.
    GHOSH S.Metabolomic studies for metabolic alterations induced by non-steroidal anti-inflammatory drugs：Mini review［J］.Biomolecules，2021，11（10）：1456.
16. 16.
    XU X Y，QIN S Y，ZHANG L F，et al.Integrated strategy for mechanism of Shenling Baizhu powder in treating ulcerative colitis based on colonic metabolomics and network pharmacology［J］.China J Chin Mater Med，2024，49（7）：1749-1761.
17. 17.
    WANG R S，HOU Y F，CAO W W，et al.Exploring mechanism of different processed products of Baiyaojian and its formula in treating ulcerative colitis based on serum metabolomics and flow cytometry［J］.Chin J Exp Tradit Med Form，2024，30（15）：172-181.
18. 18.
    YAN Y X，SHAO M J，QI Q，et al.Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages［J］.Acta Pharmacol Sin，2018，39（10）：1633-1644.
19. 19.
    XU M，DUAN X Y，CHEN Q Y，et al.Effect of compound sophorae decoction on dextran sodium sulfate（DSS）-induced colitis in mice by regulating Th17/Treg cell balance［J］.Biomed Pharmacother，2019，109：2396-2408.
20. 20.
    XIAO Q P，HUANG J Q，WAN Q，et al.Mechanism of anti-inflammatory effects of Bupi Yichang pill on inhibiting glycolytic metabolic pathway in mice with experimental colitis［J］.Tradit Chin Drug Res Clin Pharmacol，2024，35（1）：1-9.
21. 21.
    ZHANG Q，ZHANG R Y，DENG H D，et al.Antioxidant activity and therapeutic effect on ulcerative colitis of houpo（Magnolia officinalis）［J］.Chin Arch Tradit Chin Med，2024，42（8）：180-185，291-294.
22. 22.
    TONG Y L，ZHAO X，WANG R L，et al.Therapeutic effect of berberine on chronic atrophic gastritis based on plasma and urine metabolisms［J］.Eur J Pharmacol，2021，908：174335.
23. 23.
    ZHOU X X，LIU Q Q，REN Z，et al.Characteristics and application analysis of animal models of ulcerative colitis［J］.Acta Lab Anim Sci Sin，2023，31（7）：896-904.
24. 24.
    DAWISKIBA T，DEJA S，MULAK A，et al.Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases［J］.World J Gastroenterol，2014，20（1）：163-174.
25. 25.
    UPADHYAY K G，DESAI D C，ASHAVAID T F，et al.Microbiome and metabolome in inflammatory bowel disease［J］.J Gastroenterol Hepatol，2023，38（1）：34-43.
26. 26.
    KIM Y J，CHUNG H Y.Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaenoic acid in renal epithelial cells and macrophages［J］.J Med Food，2007，10（2）：225-231.
27. 27.
    FERNÁNDEZ J，DE LA FUENTE V G，GARCÍA M T，et al.A diet based on cured acorn-fed ham with oleic acid content promotes anti-inflammatory gut microbiota and prevents ulcerative colitis in an animal model［J］.Lipids Health Dis，2020，19（1）：28.
28. 28.
    SCOVILLE E A，ALLAMAN M M，BROWN C T，et al.Alterations in lipid，amino acid，and energy metabolism distinguish crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling［J］.Metabolomics，2017，14（1）：17.
29. 29.
    SHIN S，JEONG H M，CHUNG S E，et al.Simultaneous analysis of acetylcarnitine，proline，hydroxyproline，citrulline，and arginine as potential plasma biomarkers to evaluate NSAIDs-induced gastric injury by liquid chromatography-tandem mass spectrometry［J］.J Pharm Biomed Anal，2019，165：101-111.
30. 30.
    CHEN M D，LIU Y Y，XIONG S B，et al.Dietary l-tryptophan alleviated LPS-induced intestinal barrier injury by regulating tight junctions in a Caco-2 cell monolayer model［J］.Food Funct，2019，10（5）：2390-2398.
31. 31.
    WANG J，LI G R，TAN B E，et al.Oral administration of putrescine and proline during the suckling period improves epithelial restitution after early weaning in piglets［J］.J Anim Sci，2015，93（4）：1679-1688.